Colgate-Palmolive (NYSE:CL), a global leader in consumer products with a "GOOD" InvestingPro Financial Health score of 2.73, finds itself at a crossroads as it navigates a complex market environment.

July 26 (Reuters) - Toothpaste maker Colgate-Palmolive (CL.N), opens new tab raised its forecasts for annual profit and organic sales on Friday, after beating second-quarter estimates on resilient ...

Earnings Call Insights: Colgate-Palmolive Company (NYSE:CL) Q4 2024 CEO Noel Wallace highlighted net sales of $20 billion in ...

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment. (2) The ...

Colgate-Palmolive will introduce new packaging and marketing for its toothpaste products, after Texas Attorney General Ken Paxton expressed concern that its marketing of fluoride could harm parents ...

Colgate-Palmolive Co. (CL) reported better-than-expected results in the third quarter. The consumer products company reported adjusted earnings of $0.91 per share, an increase of 6% year-over-year, ...

CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ahead of their strategic plan. The company delivered high-single-digit organic sales growth for the ...